What are the alternatives for hypertension (HTN) medications that cause hair loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hypertension Medications and Hair Loss: Alternatives and Management

For patients experiencing hair loss from hypertension medications, switching to ACE inhibitors, calcium channel blockers (except diltiazem), or thiazide diuretics is recommended as these are less likely to cause alopecia.

Hypertension Medications Associated with Hair Loss

Hair loss (alopecia) can be a distressing side effect of certain antihypertensive medications. Based on the available evidence, the following medications are more commonly associated with hair loss:

  • Beta-blockers: Particularly propranolol, metoprolol, and other systemic beta-adrenoceptor antagonists 1
  • ACE inhibitors: Cases have been reported with lisinopril 2
  • Calcium channel blocker: Diltiazem (less commonly)

Preferred Alternative Antihypertensive Medications

When selecting alternative medications for patients experiencing hair loss, consider the following options:

First-line alternatives:

  • Angiotensin receptor blockers (ARBs) such as losartan, candesartan, or valsartan
  • Calcium channel blockers (particularly amlodipine or felodipine)
  • Thiazide diuretics such as hydrochlorothiazide or chlorthalidone

Treatment algorithm for patients with hypertension and hair loss:

  1. Confirm medication-induced alopecia:

    • Temporal relationship between medication initiation and hair loss
    • Diffuse pattern of hair loss (typically non-scarring)
    • Rule out other causes of hair loss (thyroid disorders, nutritional deficiencies)
  2. First medication switch options:

    • If on beta-blocker → Switch to ARB or CCB
    • If on ACE inhibitor → Switch to ARB
    • If on diltiazem → Switch to amlodipine or felodipine
  3. Optimize remaining regimen based on the 2017 ACC/AHA guidelines 3:

    • Ensure appropriate combination therapy with agents from complementary classes
    • Consider single-pill combinations to improve adherence
    • Maintain lifestyle modifications (sodium restriction, physical activity, weight management)

Special Considerations

For Resistant Hypertension

If the patient has resistant hypertension requiring multiple agents, the American Heart Association recommends a stepped approach 3:

  1. Optimize three-drug regimen with RAS blocker (ARB preferred over ACE inhibitor if hair loss is a concern), CCB, and appropriate diuretic
  2. Add mineralocorticoid receptor antagonist (spironolactone or eplerenone)
  3. Consider central α-agonists (clonidine patch or guanfacine) instead of beta-blockers
  4. Add hydralazine if needed

For Patients with Comorbidities

  • Diabetes: ARBs are particularly beneficial
  • Heart failure: Consider hydralazine with nitrates if beta-blockers cause significant hair loss
  • Chronic kidney disease: Adjust diuretic type based on eGFR

Monitoring and Patient Education

  • Inform patients that medication-induced hair loss is typically reversible upon discontinuation of the offending agent 1
  • Improvement may take 3-6 months after switching medications
  • Consider topical minoxidil as a temporary measure to manage hair loss while transitioning medications 4
  • Monitor blood pressure closely during medication transitions to ensure continued control

Common Pitfalls to Avoid

  • Don't abruptly discontinue beta-blockers - this can cause rebound hypertension; taper gradually
  • Don't ignore other potential causes of hair loss (thyroid dysfunction, nutritional deficiencies, stress)
  • Don't underestimate the psychological impact of hair loss on medication adherence and quality of life 5
  • Don't sacrifice blood pressure control for cosmetic concerns - prioritize cardiovascular risk reduction while addressing hair loss concerns

By following this approach, clinicians can effectively manage hypertension while minimizing the distressing side effect of medication-induced hair loss, thereby improving both cardiovascular outcomes and quality of life.

References

Research

Lisinopril-Induced Alopecia: A Case Report.

Journal of pharmacy practice, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Minoxidil use in dermatology, side effects and recent patents.

Recent patents on inflammation & allergy drug discovery, 2012

Research

Hair Loss: Diagnosis and Treatment.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.